Correction to: International prospective observational cohort study of Zika in infants and pregnancy (ZIP study): study protocol.

Following publication of the original article [1], the author mentioned that two additional NIH staff were involved in the development of the protocol who did not receive recognition in the Acknowledgments section in their published article.

International prospective observational cohort study of Zika in infants and pregnancy (ZIP study): study protocol.

Background: Until recently, Zika virus (ZIKV) infections were considered mild and self-limiting. Since 2015, they have been associated with an increase in microcephaly and other birth defects in newborns. While this association has been observed in case reports and epidemiological studies, the nature and extent of the relationship between ZIKV and adverse pregnancy and pediatric health outcomes is not well understood.

HIV seroconversion during pregnancy and the need for pre-exposure prophylaxis (PrEP).

The reduction in the mother-to-infant transmission of HIV has been among the early successes of care and treatment of women living with HIV. Prenatal HIV counseling and testing, the availability of diverse antiretroviral therapies, elective cesarean section, and the use of formula milk have significantly reduced the mother-to-infant transmission in the USA and Europe. We are presenting two cases of seroconversion during pregnancy, identified during labor and delivery, of women who received risk reduction counseling and serial HIV testing during pregnancy.

The Zika Virus Infection in Pregnancy: Review and Implications for Research and Care of Women and Infants in Affected Areas.

The world has encountered a new and serious epidemic which has disproportionately affected fetuses and infants. What makes the Zika virus (ZIKV) epidemic such a threat in our times, is that a whole generation can be affected by birth defects caused by a seemingly innocuous maternal infection, which in most cases go unnoticed and undiagnosed. Spreading to over 80 countries and affecting millions, it is associated with severe birth defects known as congenital Zika syndrome (CZS), which include fetal brain development abnormalities (microcephaly and brain calcifications), retinal abnormalities, and contractures and hypertonia of the extremities.

Prevalence and correlates of cervical HPV infection in a clinic-based sample of HIV-positive Hispanic women.

Objectives: Puerto Rico (PR), is the fifth highest jurisdiction of the United States of America (US) with respect to HIV prevalence and the leading in cervical cancer incidence. This cross-sectional study describes the prevalence and correlates of cervical HPV infection among a clinic-based sample of 302 women living with HIV/AIDS in PR.

Methods: Data collection included questionnaires, blood and cervical samples.

Improved Infant Outcomes with Group Prenatal Care in Puerto Rico.

Objectives: To evaluate the impact of group prenatal care () on the rate of Preterm Birth (PTB) and low birth weight. Women were enrolled into Centering Pregnancy () if they fell in the category of poverty, and had at least one risk for PTB according to known risk factors for low birth weight or PTB.

Methods: Mother's age, parity, risk factors, prenatal/delivery complications, infants' Gestational Age (GA), birth weight, Apgar scores, delivery route, indications for delivery, and use of Neonatal Intensive Care Unit (NICU) were abstracted from charts of mothers who received group or traditional care at the University Hospital in San Juan, PR.

Measuring Knowledge of Cancer Screening and Prevention Strategies in HIV Healthcare Professionals.

Objective: Due to advances in the care of people living with HIV/AIDS (PLWHA), life expectancy significantly increased, putting this group vulnerable to age-related comorbidities, such as cancer. The objective of this study was to describe the knowledge of cancer screening (cervical, breast, anal, colon, prostate) and other cancer prevention strategies (HPV vaccination, HPV testing) among HIV care professionals in Puerto Rico (PR).

Methods: Cross-sectional study using a sample of 104 HIV healthcare professionals in PR.

Pharmacologic and nonpharmacologic options for the management of HIV infection during pregnancy.

Over the past decade, significant advances have been made in the treatment of HIV-1 infection using both pharmacologic and nonpharmacologic strategies to prevent mother-to-child transmission (MTCT). Optimal prevention of the MTCT of HIV requires antiretroviral drugs (ARV) during pregnancy, during labor, and to the infant. ARVs reduce viral replication, lowering maternal plasma viral load and thus the likelihood of MTCT.

Reduction in the perinatal HIV transmission: the experience at the Maternal Infant Studies Center and Gamma Projects at the University of Puerto Rico School of Medicine.

The AIDS pandemic had a significant impact in Puerto Rico, especially among the heterosexual populations, in particular women. Women are one of the fastest growing risk groups with HIV/AIDS in the USA and constitute about half of the AIDS cases in the world. During the past 10 years Puerto Rico has ranked among the top 5 jurisdictions in the United States in AIDS cases rates, among men, women and children.

An empowerment intervention for women living with HIV and its adaptation for women with a diagnosis of breast cancer.

Because of improved therapeutic strategies, both human immunodeficiency virus (HIV) infection and breast cancer can be considered life-threatening illnesses that eventually become a chronic condition. Both diagnoses carry a psychological impact, stigma, body alterations, intense medical evaluations, and therapies. Both conditions are prevalent among minorities, especially women of Hispanic heritage.

Greater adherence to highly active antiretroviral therapy (HAART) between pregnant versus non-pregnant women living with HIV.

One of the most remarkable advances in the control of the HIV/AIDS pandemic has been the introduction of highly active antiretroviral therapy (HAART). The use of HAART has been associated to reductions in AIDS-related mortality in most countries where HAART is available. Unfortunately, the adherence required to keep good control of viral replication is higher than what is required in other medical conditions.